Skip to main content
OpenTrials
Completed

NCT Number: NCT03367858

Motivational Interviewing and Neuroimaging With Adolescents

This is a randomized controlled trial to examine the impact of two brief interventions on adolescent and young adult alcohol use behaviors and related brain response. The interventions being compared are motivational interviewing (MI) and brief adolescent mindfulness (BAM).

Completed

Looking for future studies?

Notify Me

Key information

Age range

14 year–19 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Oregon Health & Science University

Portland, Oregon, 97239, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • within the specified age range
  • >= 1 past two month binge drinking episode
  • right-handed
  • proficient in English
  • agree to be contacted for the 3, 6, and 12 month follow ups
  • informed consent of a parent/guardian, if under 18 years old
  • informed assent/consent of participating youth

Exclusion criteria

  • > 3 past-month instances of non-nicotine and/or non-cannabis substance use (e.g., methamphetamine)
  • evidence of brain injury/illness or neurological disorder including psychosis
  • lifetime loss of consciousness >= 2 min
  • unremovable metal on/in body, or other functional magnetic resonance imaging (fMRI) contraindications (e.g., pregnancy)

Treatment and study plan

Motivational Interviewing (MI)

Behavioral

Motivational interviewing introduced a conversation about alcohol use, and the personally-experienced consequences of problem drinking. The MI sessions explored youths' stories around their substance use, the factors in youths' lives that support problem drinking (e.g., what they like about drinking), and the consequences of their recent or previous problem drinking (e.g., getting in trouble). Youth were provided personalized feedback about how their problem drinking compared to age-matched norms in the U.S. The ultimate goal of the MI sessions was to engage youth in a thoughtful conversation about their problem drinking with an eye to bolstering and supporting youths' own inherent drive for behavior change.

Brief Adolescent Mindfulness (BAM)

Behavioral

Brief Adolescent Mindfulness introduced a conversation about what mindfulness is, and ways that it might be personally-relevant to adolescents' current experiences. This manualized treatment introduced concepts of eastern thought in a manner articulated to adolescents. Treatment included a discussion of factors in the youth's life that could be positively impacted by using or engaging mindful approaches (e.g., current experiences of stress) and a link to how mindful approaches might be applicable or relevant to the adolescent's problem drinking. The ultimate goal was to engage youth in a thoughtful conversation about BAM and how eastern thought and mindful approaches could unburden some aspects of their current lived experiences.

Primary outcomes

  1. Alcohol-related Problems

    Time frame: assessed at baseline, and 3-, 6-, and 12-month post-treatment follow ups; 12-month follow up reported

    Rutgers Alcohol Problems Index (RAPI) to assess alcohol-related problems. Minimum individual value = 0; maximum individual value = 92. Higher scores mean more alcohol-related problems.

Sponsors and collaborators

Lead sponsor

University of Rhode Island

Other

Registry information

Acronym: MINA

Important dates

Study start
2017
Primary completion
2020
Study completion
2020
First posted
Dec 11, 2017
Registry last updated
Nov 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.